3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

for Advanced Breast Cancer (ABC 3) F. Cardoso, A. Costa, E. Senkus, M. Aapro, F. André, C. H. Barrios, J. Bergh, G. Bhattacharyya, L. Biganzoli, M. J. Cardoso, L. Carey, D. Corneliussen-James, G. Curigliano, V. Dieras, N. El Saghir, A. Eniu, L. Fallowfield, D. Fenech, P. Francis, K. Gelmon, A. Gennari, N. Harbeck, C. Hudis, B. Kaufman, I. Krop, M. Mayer, H. Meijer, S. Mertz, S. Ohno, O. Pagani, E. Papadopoulos, F. Peccatori, F. Pernault-Llorca, M. J. Piccart, J. Y. Pierga, H. Rugo, L. Shockney, G. Sledge, S. Swain, C. Thomssen, A. Tutt, D. Vorobiof, B. Xu, L. Norton European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland; Breast Center, Genolier Cancer Center, Genolier, Switzerland; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France; Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil; Department of Oncology/Radiumhemmet, Karolinska Institutet Department of Medical Oncology, Fortis Hospital, Kolkata, India; Medical Oncology Department, Hospital of Prato, Prato, Italy; Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal; Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center; METAvivor Research and Support, Annapolis, USA; Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy; Department of Medical Oncology, Institut Curie, Paris, France; NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon; Department of Breast Tumors, Cancer Institute ‘I. Chiricuta’, Cluj-Napoca, Romania; Brighton Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia; BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada; Department of Medical Oncology, Galliera Hospital, Genoa, Italy; Brustzentrum der Universitat München, Munich, Germany; Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA; Sheba Medical Center, Tel Hashomer, Israel; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Advanced Breast Cancer.org, New York, USA; Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands; Metastatic Breast Cancer Network US, Inversness, USA; Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan; Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland; Europa Donna, Nicosia, Cyprus; European School of Oncology, Milan, Italy and Bellinzona, Switzerland; Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France; Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France; Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco; Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore; Indiana University Medical CTR, Indianapolis; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA; Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany; Breakthrough Breast Cancer Research Unit, King’s College London and Guy’s and St Thomas’s NHS Foundation Trust, London, UK; Sandton Oncology Centre, Johannesburg, South Africa; Department of Medical Oncology, Chinese Academy of Medical Sciences Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA